Pharma-Bio Serv Inc. (OTCMKTS:PBSV – Get Free Report)’s share price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.53 and traded as low as $0.4225. Pharma-Bio Serv shares last traded at $0.4225, with a volume of 100 shares changing hands.
Pharma-Bio Serv Stock Performance
The firm has a 50-day moving average price of $0.53 and a two-hundred day moving average price of $0.53.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) last announced its earnings results on Monday, June 15th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). Pharma-Bio Serv had a net margin of 0.68% and a return on equity of 0.56%. The firm had revenue of $2.70 billion during the quarter, compared to analyst estimates of $2.70 million. Research analysts anticipate that Pharma-Bio Serv Inc. will post 0.07 EPS for the current fiscal year.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.
See Also
- Five stocks we like better than Pharma-Bio Serv
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.
